Background: Symptomatic gallstone is one of the most common diseases in Taiwan. The aim of this study was to develop a Mandarin Chinese outcomes measure for the assessment on quality of life among gallstone patients.
INTRODUCTION S
ymptomatic gallstone is one of the most common diseases in the world; laparoscopic cholecystectomy (LC) is currently the standardized management for the treatment gallstone. [1] [2] [3] [4] [5] Since the 1990s, several articles have been published regarding the severity of symptoms, nature of gallstones, and benefits and risk of LC, based on the information obtained from some 5500 LC surgeries performed in the Cathay General Hospital (Taipei, Taiwan). [6] [7] [8] [9] [10] [11] It is obvious that LC indeed benefits patients, especially for those with severe symptoms. Unfortunately, limited studies have focused on the quality of life among patients with gallstone; and the health-related quality-of-life status following LC remains unknown among the Chinese-speaking population, which is in need of a patient-centered outcomes measure to gain a more comprehensive insight of gallstone patients' wellbeing.
The Gastrointestinal Quality of Life Index (GIQLI) is a validated outcomes measure designed to evaluate health impact and treatment effectiveness for adults with chronic gastrointestinal conditions. The GIQLI has been used to identify quality-of-life consequences of chronic gastrointestinal conditions, such as physical symptoms, mental problems, digestion, and defecation associated with gastrointestinal diseases. Whereas treatment effectiveness in chronic gastrointestinal conditions have been established through conventional studies, the patient-based GIQLI enables physicians to understand the effects of gastrointestinal diseases and its intervention on the functioning and well-being of patients from their point of view. [12] [13] [14] The need for quality-of-life instruments is global; ideally, similar instruments will be used in different cultures to allow for comparison and collaboration. However, because different cultures adopt different values and norms, a linguistic translated instrument must also be appropriately adapted and evaluated in culture.
There is currently no validated Chinese-language quality-of-life instrument to evaluate patients with chronic gastrointestinal disease. Rather than design a new instrument, it is believed that having a common tool available in both English and Chinese will make it possible to combine data from various centers worldwide for analysis. A uniform gastrointestinal outcomes measure will provide cross-cultural quality-of-life information and provide a way to compare treatment effectiveness under different health care systems. The aims of this study were to translate and validate a Chinese (Taiwan) version of the GQLI (CGIQLI), and to compare the performance characteristics between the CGIQLI and the original GIQLI. The performance characteristics of a quality-oflife measure include its validity, reliability, and responsiveness to clinical change.
MATERIALS AND METHODS

The GQOLI
The GIQLI was originally developed by Eypasch et al. 12 The GIQLI is a 36-item survey that evaluates the physical and mental problems associated with chronic gastrointestinal disease on a Likert scale; each survey question has five response options (0-4, worst to best condition). The GIQLI generates a total score and four subscale scores (physical well-being 0-40, mental wellbeing 0-20, gastrointestinal digestion 0-40, and gastrointestinal defecation 0-24). The physical well-being subscale reflects the limitations in physical or social activities directly related to chronic gastrointestinal conditions. The three remaining subscales are reflective of a patient's mental, digestive, and defecation problems. Survey total and subscale scores are normalized on a 0 ("worst") to 144 ("best") scale based on published algorithms. The GIQLI was designed to evaluate adult patients with chronic gastrointestinal diseases.
Instrument translation
The production of the Chinese (Taiwan) version of the GIQLI followed the standard forward, backward, and pretest steps for instrument translation. Authorization to translate was secured in advance. The GIQLI was first translated into Mandarin Chinese and then back into English iteratively by two bilingual physicians, until the two versions were considered completely interchangeable. A bilingual lay panel consisting of three heterogeneous individuals was then used to measure comprehensibility, test translation alternatives, highlight unexpected errors, and reveal inappropriate survey items.
Study population
One hundred and two (102) consecutive adult patients with a diagnosis of symptomatic gallstone disease were prospectively enrolled. Diagnosis was made based on symptoms consistent with cholecystitis (i.e, right-upper quadrant abdominal pain with or without back or shoulder radiation, fat meal intolerance, nausea and vomiting, etc.) and the sonographic presence of gallstones. Diagnoses for all patients were later histopathologically confirmed after surgery.
Survey forms
Upon entry into this study, all patients received the selfadministered CGIQLI and the research-validated Mandarin Chinese (Taiwan) version Medical Outcome Study 36-Item Short-Form Health Survey (SF-36). [15] [16] [17] Permission to use the SF-36 was obtained from the Medical Outcomes Trust of Boston. The SF-36 is a widely used, generic quality-of-life measure with eight domains of general health, including: physical function (PF), role functioning-physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role functioning-emotional problems (RE), and mental health (MH). Scores are tabulated according to published algorithms from 0 ("worst") to 100 ("best"). [18] [19] [20] Reliability of the CGIQLI Fifty-six (56) patients with symptomatic gallstone disease awaiting surgical scheduling and without known interval clinical change from treatment were retested with the CGIQLI after a 2-to 4-week interval. The Spearman VALIDATION ASSESSMENT OF THE CGIQLI 431 rank-order correlation coefficients were used to determine the test-retest reliability for subscales, as well as for total survey scores; the item-total, subscale-subscale, and subscale-total correlations were also calculated by using the same statistical method. Cronbach's ␣ correlation coefficients were used to calculate the internal consistency of the CGIQLI.
Validity of the CGIQLI
The CGIQLI was assessed for convergent and divergence validity through correlations to validated SF-36. A total of 102 complete sets of the CGIQLI and SF-36 were obtained.
Responsiveness of the CGIQLI
All 102 patients participating in the validity test were again tested with the CGIQLI 2 months after standard LC surgery. The conditions of these patients were determined by their physicians to have had clinical recovery based on standard criteria at the 2-month postoperative evaluation. Longitudinal sensitivity to clinical change was calculated as the standardized response mean (SRM ϭ response mean/response standard deviation), according to methodology described by Liang et al. 21 
Statistical analysis
All data were stored in Access 7.0 database (Microsoft; Redmond, Seattle). Analyses were conducted using STATA software package (STATA Corp; College Station, TX).
RESULTS
Study population
The mean age for these 102 patients was 49.7 Ϯ 13.6 years (range, 23-75); 69 of the patients (67.7%) were female and 33 (32.3%) were male. Fifty-six (56) patients (54.9%) participated in the retest.
Reliability of the CGIQLI
Internal consistency. Cronbach's ␣ correlation coefficients for internal consistency was 0.80 for the physical well-being subscale, 0.88 for the mental well-being subscale, 0.84 for the gastrointestinal digestion subscale, 0.57 for the gastrointestinal defecation subscale, and 0.92 for the total survey. The comparisons of internal consistency between the GIQLI and CGIQLI are shown in Table 1 .
Intrasurvey reliability. The item-total, intersubscale, and subscale-total correlation coefficients are tabulated in Tables 2 and 3 . Overall, the individual items correlated well with the total score (P Ͻ 0.001). The item-total correlation coefficients varied from 0.50 (item 8) to 0.89 (item 11). The intersubscale correlations vary from 0.49 (mental well-being with gastrointestinal defecation) to 0.69 (gastrointestinal defecation with gastrointestinal digestion) (P Ͻ 0.05). The subscale scores all correlated well with the total survey score (P Ͻ 0.001). The subscale-total correlation coefficients ranged from 0.77 (gastrointestinal defecation) to 0.86 (physical well-being and gastrointestinal digestion).
Test-retest reliability. The test-retest reliability of individual subscales and total score are high; the correlation coefficients for physical well-being, mental well-being, gastrointestinal digestion, gastrointestinal defecation subscores, and total score were 0.93, 0.95, 0.90, 0.86, and 0.92, respectively (P Ͻ 0.001) ( Table 4) .
Validity of the CGIQLI
The correlations between CGIQLI and the eight subscale scores of the SF-36 are shown in Table 5 . Overall, the CGIQLI physical well-being, mental well-being, gastrointestinal digestion, and gastrointestinal defecation subscale scores demonstrated significant correlations with most of the SF-36 subscale scores, except for the poorer correlation between the SF-36 MH and CGIQLI gastrointestinal defecation subscales (r ϭ 0.14). The CGIQLI total score correlated well with all the SF-36 subscale scores; the correlation coefficients varied from 0.29 to 0.62.
Responsiveness of the CGIOLI
Of the 102 patients who underwent clinically successful LC, the SRM for the CGIQLI total score was 0.967, indicating an excellent responsiveness or sensitivity to clinical change. The SRM for physical well-being, mental well-being, gastrointestinal digestion, and gastroin- testinal defecation subscale scores were 0.647, 0.692, 1.08, and 0.493, respectively.
DISCUSSION
Understanding disease-related quality of life and health status is a global issue for practice physicians. Outcomes data collected from various health care systems can enhance our understanding of disease impact and its treatment effectiveness. A significant percentage of the world population reports Chinese as their primary language and this demographic is growing. In the past, there has been no Chinese instrument available to assess quality-of-life outcomes for patients with chronic gastrointestinal diseases. This study demonstrated that the Chinese (Taiwan) version of the GIQLI is a valid, disease-specific health measure that can be used to evaluate adult patients with chronic gastrointestinal problems among the Chinesespeaking population.
The aim for a cross-cultural adaptation of an outcomes measure is to remove the difficulties barring the optimal transfer of informational, emotional, and stylistic content of the original survey. Development of the CGIQLI has followed the standard forward, backward, and pretest steps for instrument translation. The parallel model approach used in this study sought to establish a basis for cross-national comparability in the original validation stages of the GIQLI.
The CGIQLI demonstrates robust test-retest reliability for subscales, as well as for its total score. The test-retest reliability for the physical well-being, mental well-being, gastrointestinal digestion, and gastrointestinal defecation subscale scores, as well as for the total score (correlation coefficients ranged from 0.86 to 0.95) all exceeded the excellent level of statistical association (Ͼ0.8). Internal consistency for the CGIQLI total score (Cronbach's ␣ ϭ 0.92) exceeded the recommended level of 0.7 commonly used to establish a reliable measure for population studies 22 and is comparable to the English version of the GIQLI (0.93). 12 Correlations of the CGIQLI with the SF-36 general health measure are used as a test of convergent validity. The Chinese (Taiwan) version of the SF-36 was validated through standard statistical procedures used previously by other researchers. 16, 17 The CGIQLI total survey score shows significant correlations with all eight subscales of the SF-36, including PF, RP, BP, GH, VT, SF, RE, and MH. These significant correlations also imply that symptomatic gallstone disease might have remarkable impact on a patient's general health.
Responsiveness, or sensitivity to longitudinal change, is the ability of a health instrument to detect clinical change over time. The CGIQLI demonstrates a very high standardized response mean (0.967), indicating excellent responsiveness to clinical change (a value of 0.2 or less is poor, 0.5 is moderate, and 0.8 or greater is excellent responsiveness). 22, 23 Hence, the CGIQLI meets the criteria for a sensitive instrument that can be used in clinical studies of therapy for chronic gastrointestinal diseases.
CONCLUSIONS
This study demonstrated that the CGIQLI is a valid, reliable, and sensitive tool for outcomes measurement. The validation demonstrates only minor language effects; the statistical properties of CGIQLI are compatible with the English version of the GIQLI. The CGIQLI is a validated equivalent of the GIQLI that can be used to measure quality-of-life outcomes of chronic gastrointestinal diseases among billions of adults in the Chinese-speaking population. With the validated CGIQLI, clinicians are able to conduct further studies on the quality of life and treatment effectiveness for patients with gallstone.
